AGILON HEALTH SHAREHOLDER ALERT FROM FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses Exceeding $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against agilon Health, Inc. – AGL

NEW ORLEANS, May 10, 2024 /PRNewswire/ — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Louisiana Attorney General Charles C. Foti, Jr., remind investors that they still have time have May 20, 2024 Filing lead plaintiff motions in a securities class action lawsuit against Agilon Health, Inc. (“agilon” or the “Company”) (NYSE: AGL) if it: i) sold the Company’s shares between April 15, 2021 and February 27, 2024, inclusive ( the “Class Period”) and/or ii) purchased or otherwise acquired the Company’s shares as part of the Company’s initial public offering in April 2021 and/or iii) the Company’s shares as part of the Company’s initial public offering purchased or otherwise acquired in May 2023 (“SPO”). These lawsuits are pending in the U.S. District Courts for the Western District of Texas and the Southern District of New York.

What you can do

If you have purchased or otherwise acquired shares in agilon as above and would like to discuss your legal rights and the possible impact of these cases on you and your right to compensation for your economic loss, you can contact the managing partner of agilon without obligation and at no cost to you KSF contact Lewis Kahn toll-free at 1-877-515-1850 or email ([email protected]) or visit https://www.ksfcounsel.com/cases/nyse-agl/ to learn more experience. If you wish to serve as lead plaintiff in the class action lawsuits, you must petition the courts May 20, 2024.

About the complaints

Agilon and certain of its executives are accused of failing to disclose material information during the Class Period, thereby violating federal securities laws.

On January 5, 2024, the company announced that it would cut its 2023 earnings guidance, specifically its 2023 medical margin expectation to “$340 million to $360 million, approximately $110 million below the previous guidance range…due to higher $90 million “in expected medical costs” and that its chief financial officer, Timothy Bensley, would retire and be replaced later in the year.

On this news, agilon’s share price fell $3.45, or 28.6%, to close at $8.63 on January 5, 2024.

The first case filed is New England Teamsters Pension Fund v. agilon Health, Inc., 24-cv-00297. A second case, Hope v. Agilon Health, Inc., 24-cv-00305, extended instruction time. A third case, Indiana Public Retirement System v. agilon Health, Inc., 24-cv-2506, Extended Class Period and Class Definition.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s leading boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, asset managers and retail investors – in obtaining compensation for investment losses resulting from corporate fraud or misconduct by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana and New Jersey.

To learn more about KSF, visit www.ksfcounsel.com.

Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, managing partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

View original content to download multimedia: https://www.prnewswire.com/news-releases/agilon-health-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick–foti-llc -reminds- investors-with-losses-over-100,000-the-lead-plaintiff-deadline-in-class-action-actions-against-agilon-health-inc—agl-302142629.html

SOURCE Kahn Swick & Foti, LLC